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Summary: Six patients with PSC have been diagnosed and followed up at a centre in Northern India 
for periods upto 4 years. They all presented with cholestatic jaundice and cholangitis, but one of them 
subsequently presented with variceal haemorrhage. Cholangiographic features were the most charac- 
teristic and included irregular narrowing and segmental dilatation of the biliary radicles giving them a 
beaded appearance. Treating them was most frustrating. Two of them died of hepatic encephalopathy, 
others have also continued to be sick during the follow-up. Gastroenterol Jpn 1989;24:75-79 
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Introduction 
Primary sclerosing cholangitis (PSC) is a well 
recognised clinical entity with distinct clinical, 
biochemical, histological and radiological fea- 
tures 1'2. Most of the case reports and reviews on 
the subject have however, or iginated from 
western countries. Only one case report has 
been publ ished to date from India 3. Is it yet 
another disease that has a predilection for the 
affluent western societies? This prompted us to 
report our experience of 6 such cases of PSC 
diagnosed at the All India Institute of Medical 
Sciences, New Delhi. 
Materials and Methods 
During the period, May 1983 - March 1987, six 
patients were diagnosed as having pr imary 
sclerosing cholangitis on the basis of character- 
istic cholangiographic features (4 cases) and 
laparotomy f indings (2 cases). Each of them was 
fully assessed clinically as well as with the help 
of laboratory, endoscopic and radiographic 
procedures, and then followed closely by us for 
different t ime periods. The details of their 
investigative and clinical data are given below. 
Results 
The ages of these patients ranged from 19 to 55 
years with a mean of 36.1 years; four (66.6%) of 
them were below 30 years of age. Only one of 
them was female. The patients presented to our 
centre after a mean period of 31.1 months (range 
8-84 months)  following the onset of symptoms,  
which was ins iduous in all cases. Jaundice was 
the present ing feature in four patients (66.6%) 
whereas pruritus and pain in the right upper  
quadrant  of the abdomen were the initial 
symptoms in one patient each. The symptoms 
and signs of these patients are shown in Table 
1. Jaundice, generalised weakness and mod- 
erate hepatomegaly were seen in all the pa- 
tients. Episodic fever suggestive of cholangitis, 
r ight upper  abdominal  pain and pruritus were 
seen in about two-thirds of the patients. Even 
though splenomegaly was detected in half of 
the patients, only one patient had an episode 
of variceal haemorrhage. The mean size of 
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Table 1 Clinical features of PSC 
Clinical features No. % 
Jaundice 6 100 
Pruritus 4 66.6 
Pain in abdomen 4 66.6 
Fever 5 83.3 
Lethargy & Fatigue 6 100 
UGI bleeding 1 16.6 
Features of hepatocellular 
decompensatien 
a. Ascites, Oedema 2 33.3 
b. Other features 0 0 
Hepatomegaly 6 100 
Splenomegaly 3 50 
Extra hepatic manifestations: 
a. Ulcerative colitis 2 33.3 
b. Pyoderma gangrenosum 1 16.6 
(N=6) 
hepatomegaly was 4.5 cm below the right costal 
margin whereas in all the patients with sple- 
nomegaly the spleen was palpable less than 
2 cm below the left costal margin. None of the 
patients had features of hepatocellular decom- 
pensat ion on presentation. However, two 
patients developed ascites and dependent  
oedema during the follow-up. 
Features uggestive of ulcerative colitis were 
seen in 2 patients in whom a proctosigmoi- 
doscopy and rectal b iopsy confirmed the diag- 
nosis. One patient with ulcerative colitis also 
had pyoderma gangrenosum. In one patient, 
the features of colitis preceded the onset of PSC 
by 4 years, whereas in the other the features 
appeared one year after the development of 
PSC. 
The laboratory parameters are depicted in 
Table 2. All the patients had haematological 
evidence of 'chronic infection" in the form of 
low haemoglobin and polymorphonuclear 
leucocytosis. Serum bi l irubin was always less 
than 10 mg/dl  except in one patient in whom it 
was 26.6 mg/dl. Serum alkaline phosphatase 
was raised more than three-fold in all the 
patients except one in whom it was normal. 
Serum transaminases were moderately raised. 
Serum proteins were normal in all the patients 
and the prothrombin t ime (PT) was slightly 
prolonged in only two patients. None of the 
Table 2 Laboratory parameters in PSC 
Laboratory parameters Mean value Range 
Haemoglobin (G/dl) 10.8 7.4 to 11.8 
Total leucocyte count/cu mm 15,766 7,000 to 27,700 
S. bilirubin-total (mg/dl) 8.0 3.0 to 26.6 
conjugated 6.0 2 to 19.4 
Serum alkaline phosphatase 57 11 to 102 
(KA units) 
SCOT (Karmen units) 76 35 to 115 
SGPT (Karmen units) 56 40 to 62 
Total serum proteins (G/dl) 7.1 5.7 to 8.4 
Serum albumin (G/dl) 4.0 3.0 to 4.4 
Prothrombin time (seconds) 3.5 0 to 6 
(n=6) 
patients showed a positive LE cell phenome-  
non. Ant imitochondrial  nt ibody and HBsAg 
were absent in all of them. 
Ultrasonographic findings were not signifi- 
cant. Only in two patients mild dilatation of 
the intrahepatic biliary radicles was seen with 
a slight di latation of the common bile duct. 
However, the thickened, irregular hyperechoic 
wall of the common bile duct in one patient 
raised a strong suspicion for the diagnosis of 
PSC before cholangiography was contem- 
plated. 
Routine upper  gastrointestinal endoscopy 
revealed the presence of esophageal varices in 
two patients (33.3%) one of whom bled from the 
varices at a later stage. 
Needle liver biopsy was done in three pa- 
tients. Extensive intracellular as well as can- 
alicular cholestasis was observed in all the three 
patients. In one of them, a diagnosis of extra- 
hepatic biliary obstruction was given because 
of which he was subjected to laparotomy in 
which the common bile duct was found exten- 
sively sclerosed and the liver grossly cirrhotic. 
In another however,  a histologic suspicion of 
sclerosing cholangitis was made because of the 
paucity of bile ducts and the presence of 
inf lammatory cell infiltration in the walls of the 
remaining biliary channels. The third patient 
simply had intrahepatic cholestasis. 
Cholangiography was done in four patients- 
percutaneous transhepatic cholangiography in 
one and endoscopic retrograde cholangio- 
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Fig. 1 Endoscopic retrograde cholangiography showing irregular 
narrowing of the common hepatic duct with proximal dila- 
tation. 
Fig. 2 Endoscopic retrograde cholangiography showing severe 
sclerosis and beading of intrahepatic biliary ducts. 
graphy in three patients. Evidence of involve- 
ment of both intra and extrahepatic ducts was 
seen in three patients. In the fourth patient, 
only intrahepatic duct involvement was seen. 
Irregular narrowing with focal dilatation was 
the most common biliary channel abnormality 
(Fig. 1). Total sclerosis of the CBD and in- 
trahepatic biliary ducts was seen in one case 
(Fig. 2). Gallbladder and pancreatic ducts were 
normal in all the four patients. The cholangio- 
graphic features in all these patients had sug- 
gested the diagnosis of primary sclerosing 
cholangitis. In the other two patients the diag- 
nosis was made on laparotomy, in which the 
CBD was seen to be sclerosed throughout its 
length. The status of intrahepatic hannels 
could however, not be assessed in these two 
patients. One of them also had cirrhotic 
changes in the liver. None of the patients had 
any evidence of choledocholithiasis on ultra- 
sonography, cholangiography or laparotomy. 
Both these patients had left hepaticodocho- 
jejunostomy with jejuno-jejunostomy. 
The two patients who had undergone 
laparotomy were unfortunately lost to follow- 
up. The remaining four patients were followed 
up from 6 months to 4 years (6 months, 6 
months, 3years, 4 years). Two of them died due 
to hepatocellular decompensation a d hepatic 
encephalopathy-one after 6 months and the 
other after 4 years of follow up. All these four 
patients were treated with prednisolone 40-60 
mg/day with azathioprine 50 to 100 mg/day and 
antibiotics as and when necessary, but none 
showed any improvement in liver function. 
Discussion 
PSC is known to be the disease of the young, 
60% of the patients being below 40 years of 
age 1-4. Most of our patients were below the age 
of 30 years. Males out-number the females in all 
the series 1, as in the present one. The patients of 
PSC invariably are symptomatic for about 2 
years before the diagnosis is made 4. In our 
patients however, more time (mean, 31 months) 
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had elapsed after the onset of symptoms before 
a diagnosis of PSC could be made. Such a delay 
in diagnosis in India is obviously because of 
lack of wide awareness of the disease and the 
l imited availability of the cholangiographic 
techniques. 
The clinical presentation of our patients com- 
prised of cholestatic jaundice with fluctuations, 
episodes of cholangitis, right upper abdominal 
pain, a moderate tender hepatomegaly, fre- 
quently encountered minimal splenomegaly 
with infrequent association of hepatocellular 
decompensation and variceal haemorrhage. 
PSC is well known to present in three forms 1"2'5 
(a) cholestatic jaundice with fluctuations and 
cholangitis (b) cryptogenic cirrhosis or chronic 
active hepatitis with portal hypertension and 
(c) asymptomatic. The first form of presentation 
is the most frequent. Indeed, all our patients 
initially presented with cholestatic jaundice 
and attacks of cholangitis. Only one patient had 
variceal haemorrhage although two patients 
had esophageal varices on endoscopy. 
Ulcerative colitis is the disease most com- 
monly associated with PSC (54-74% cases) 1'2. 
Two (33%) of our patients had ulcerative colitis 
confirmed by proctosigmiodoscopy and rectal 
biopsy. Usually the bowel disease preceeds the 
cholangitis s but in one of our patients the 
features of ulcerative colitis succeeded the 
manifestations of PSC. Pyoderma gangre- 
nosum was also seen in one of our patients with 
ulcerative colitis. 
Laboratory tests are not diagnostic. They only 
indicate the presence of cholestatic jaundice 
and infection as seen in our patients in the form 
of raised bil irubin and serum alkaline phos- 
phatase (markedly in 5 patients) and moder- 
ately raised serum transaminases, and in that of 
low haemoglobin and marked leucocytosis. The 
clinical suspicion of obstructive jaundice was 
logically followed by ultrasonography in our 
patients. That did not show the classical dilated 
intrahepatic biliary radicles. However, in two 
patients a minimal dilatation of the biliary 
radicles was seen and in one patient the CBD 
was irregular, thick walled and dilated, which 
again was not a specific feature for PSC on 
ultrasonography. Ultrasonography is therefore 
not helpful unless the clinical suspicion is high 
or the latter set of findings are obtained, in 
either of which case ERCP should be done. In 
the absence of these however, a negative 
ultrasonography would be followed by a liver 
biopsy which is known to provide a variable 
histological picture in PSC, ranging from in- 
trahepatic holestasis to cirrhosis of the liver 1-s. 
In fact, of three patients in whom liver biopsy 
was done, only in one was a diagnosis of PSC 
suspected. Thus, the rational approach in such 
cases of long-standing cholestasis with 
cholangitis in whom ultrasonography as not 
shown the classical features of obstructive 
jaundice, should be to do a cholangiographic 
study. Four of our patients had cholangio- 
graphy and in three of them both extra and 
intrahepatic biliary radicles were involved with 
characteristic irregular narrowing and seg- 
mental dilatation giving a beaded appearance. 
In the fourth patient only intrahepatic radicles 
were involved. In the remaining two patients 
laparotomy revealed a sclerosed thickened 
common bile duct, and cirrhosis of the liver. 
Even though the status of intrahepatic biliary 
radicles could not be known, the presence of 
cirrhotic changes in the liver of these patients 
made us believe that very likely intrahepatic 
ducts must be involved. Involvement of both 
intra and extrahepatic biliary ducts at the time 
of presentation is encountered in 90-95% of the 
patients with PSC 1'2'6'7. Isolated involvement of 
the biliary radicles is a rare feature. The 
maximum brunt of the disease is at the hilar 
biliary radicles 1-4'6'7. In all the three patients 
with intra and extrahepatic biliary channel 
involvement in the present series, the hilar 
radicles were grossly irregular and narrow, 
with focal dilatation, confirming the character- 
istic changes described in the literature. None 
of the patients in our series had pancreatic and 
gallbladder involvement which is encountered 
in 7-10% of the cases 1'2. It is presumed that the 
disease process in PSC starts in the intrahepatic 
biliary radicles 2. However, only serial cholan- 
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giographic follow-up in patients with isolated 
intrahepatic biliary channel involvement can 
answer this question. Unfortunately, the only 
patient who had an isolated involvement of 
intrahepatic biliary channels died of hepatic 
encephalopathy after 6 months of follow up. 
Therapy in these patients has remained un- 
satisfactory 1'2. The use of corticosteroids 8, im- 
munosuppressive agents 9, cholestyramine 1~ 
and long term antibiotics has been of no avail. 
One prevailing and promising therapeutic 
approach is a combination of surgery and inter- 
ventional radiology 2. Another one is per- 
cutaneous transhepatic biliary dilation or irri- 
gation of biliary three 1114 and more recently, 
endoscopic sphincterotomy followed by bal- 
loon dilation or stent placement 15. The prog- 
nosis is gloomy although variable1-4; the sur- 
vival after clinical detection is between 2 and 10 
years 16. Although long asymptomatic periods 
are known to occur in PSC, in none of our 
patients we encountered a complete symptom- 
free interval. On the other hand, 2 out of 4 
patients in our follow-up expired, hepato- 
cellular failure being the cause of death in both. 
Both of them had gone to the stage of cirrhosis. 
To expect any possible improvement in the 
outcome of patients with PSC, early diagnosis 
and intervention are necessary and for that an 
awareness of its clinical as well as cholangio- 
graphic features. 
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